scholarly journals TLR1 polymorphisms are significantly associated with the occurrence, presentation and drug-adverse reactions of tuberculosis in Western Chinese adults

Oncotarget ◽  
2017 ◽  
Vol 9 (2) ◽  
pp. 1691-1704 ◽  
Author(s):  
Wu Peng ◽  
Hao Chen ◽  
Zhenzhen Zhao ◽  
Xuejiao Hu ◽  
Yi Zhou ◽  
...  
2011 ◽  
Vol 131 (2) ◽  
pp. 237-238
Author(s):  
Ryuichi HASEGAWA ◽  
Masaru IWASAKI

2018 ◽  
Vol 10 (5) ◽  
pp. 555 ◽  
Author(s):  
Heung-Woo Park ◽  
Sang-Heon Kim ◽  
Yoon-Seok Chang ◽  
Sang-Hoon Kim ◽  
Young-Koo Jee ◽  
...  

2017 ◽  
Vol 66 ◽  
pp. 72-81 ◽  
Author(s):  
E.A. Voss ◽  
R.D. Boyce ◽  
P.B. Ryan ◽  
J. van der Lei ◽  
P.R. Rijnbeek ◽  
...  

2003 ◽  
Vol 12 (2) ◽  
pp. 95-99 ◽  
Author(s):  
Anna Wozniacka ◽  
Anna Sysa-Jedrzejowska ◽  
Ewa Robak ◽  
Zbigniew Samochocki ◽  
Malgorzata Zak-Prelich

Background:The association of allergic diseases, drug adverse reactions and elevated total immunoglobulin E (IgE) concentration in systemic lupus erythematosus patients remains controversial. The aim of the study was to investigate the prevalence of those features in active and inactive systemic lupus erythematosus patients, and in the control group as well.Methods:Total IgE concentration was evaluated by enzyme-linked immunosorbent assayResults and conclusions:The results of our study revealed that concomitant allergic diseases were not more frequent in systemic lupus erythematosus patients than in the general population. Total IgE concentration was significantly higher during the active stage of the disease. Drug reactions were very frequent but not connected with IgE elevation. Our results indicate that IgE may play a role in lupus pathogenesis, especially in the active phase of the disease.


1974 ◽  
Vol 13 (03) ◽  
pp. 169-178 ◽  
Author(s):  
Margaretha Helling ◽  
J. Venulet

Recording and classifying drugs reported in relation to suspected drug adverse reactions by fifteen countries has required the development of a special system. A comprehensive cross reference system between different types of drug names (INN, other nonproprietary names, trade names, etc.) and their occurrence in single and multiple ingredient products has been developed. Separate pharmacologic and therapeutic classifications designed for the needs of drug monitoring provide for farther special grouping.On the basis of accumulated data, some analysis is given of reporting patterns and drug profiles in different countries.


2007 ◽  
Vol 119 (1) ◽  
pp. S40
Author(s):  
M. Palma-Carlos ◽  
M. Medina ◽  
A.G. Palma-Carlos

Sign in / Sign up

Export Citation Format

Share Document